HeartBeam (Nasdaq: BEAT) said today that it has signed a professional services agreement with Triple Ring Technologies to help develop and design its personal, portable heart attack detector.
Santa Clara, California-based HeartBeam said it plans to submit what it calls a “telehealth complete solution 3D vector electrocardiogram (ECG) collection device” for FDA 510(k) clearance in the fourth quarter of 2022.
The company said patients will be able to use the credit-card-sized device at home to help their doctors determine whether chest pain is due to a myocardial infarction (the medical term for a heart attack) using cloud-based software for real-time data transmission.
The project includes device builds for design verification and validation, device packaging and a manufacturing technology transfer. HeartBeam said it is talking with several contract manufacturers.
“The joint effort will be a five-phase expedited device development proje…